Supply Chain | July 12, 2025
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
The company recorded its quarterly consolidated revenue from operations at Rs. 61.22 crore in Q4 FY25
Subscribe To Our Newsletter & Stay Updated
